ticarcillin has been researched along with Escherichia coli Infections in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, J; Liu, W; Zhao, F | 1 |
| Brugger, HP; Feller, C; Gerber, AU | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Duncanson, FP; Norden, CW; Talan, DA; Tan, JS; Wishnow, RM | 1 |
| Chardon, H; Farzaneh, S; Jarlier, V; Labia, R; Nicolas, MH; Paul, G; Poyart, C; Sirot, D; Sirot, J | 1 |
| Chen, Y; Gao, L; Hou, F; Li, J | 1 |
| Naumann, P; Rosin, H | 1 |
| Geedes, AM; Hutchison, JG; Mahood, CB; McGhie, D | 1 |
| Proctor, RA | 1 |
| Craig, WA; Golenbock, DT; Leggett, JE; Proctor, RA; Raetz, CR; Rasmussen, P | 1 |
| Al-Sabbagh, A; McCracken, GH; Olsen, KD; Syrogiannopoulos, GA | 1 |
| Bouhoutsou, D; Kafetzis, D; Kosmidis, H; Koupari, G; Papadatos, C; Varvoutsi, M | 1 |
| Aldridge, KE; Derks, FW; Marier, RL; Martin, DH; Sanders, CV | 1 |
1 review(s) available for ticarcillin and Escherichia coli Infections
| Article | Year |
|---|---|
Endotoxin biosynthetic precursors: biologic and therapeutic activities.
Topics: Animals; Endotoxins; Escherichia coli Infections; Glycolipids; Humans; Lipid A; Mice; Mice, Inbred C57BL; Sheep; Ticarcillin | 1989 |
3 trial(s) available for ticarcillin and Escherichia coli Infections
| Article | Year |
|---|---|
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
Topics: Bacteroides Infections; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Tazobactam; Ticarcillin | 1993 |
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections | 1998 |
Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.
Topics: Agranulocytosis; Azlocillin; Child; Clinical Trials as Topic; Escherichia coli Infections; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Ticarcillin | 1987 |
12 other study(ies) available for ticarcillin and Escherichia coli Infections
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Escherichia coli; Escherichia coli Infections; Kinetics; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1984 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Ticarcillin | 1995 |
[Progress in antibacterial chemotherapy].
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Humans; Klebsiella Infections; Penicillins; Ticarcillin | 1978 |
New penicillins in the treatment of urinary tract infection.
Topics: Amoxicillin; Ampicillin; Carbenicillin; Escherichia coli; Escherichia coli Infections; Humans; Penicillin Resistance; Penicillins; Pivampicillin; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections | 1975 |
Lipid X protects mice against fatal Escherichia coli infection.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Escherichia coli Infections; Glycolipids; Mice; Penicillins; Sepsis; Ticarcillin | 1988 |
Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.
Topics: Animals; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Escherichia coli Infections; Meningitis; Meningitis, Haemophilus; Microbial Sensitivity Tests; Penicillins; Rabbits; Ticarcillin | 1987 |
Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women.
Topics: Acute Disease; Adolescent; Adult; Aged; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Humans; Middle Aged; Penicillins; Piperacillin; Pyelonephritis; Ticarcillin | 1985 |